4.7 Article

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Schizophrenia

Sameer Jauhar et al.

LANCET (2022)

Article Biochemistry & Molecular Biology

The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study

Antoine Rogeau et al.

Summary: The current study found that gray matter volume in the prefrontal cortex is positively associated with D2/3R availability in the whole striatum, mainly driven by associative receptor availability. There is also an interaction effect between sensorimotor striatum D2/3R availability and anterior cingulate Glx, indicating a possible modulation of D2/3R availability by anterior cingulate glutamate concentrations.

MOLECULAR PSYCHIATRY (2022)

Article Neurosciences

A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach

Mattia Veronese et al.

Summary: The study evaluated the potential of [F-18]FDOPA PET imaging to identify non-responders to antipsychotic treatment using linear and non-linear machine learning analyses and found good test-retest reproducibility and predictive power in distinguishing responders from non-responders. The economic analysis indicated potential healthcare cost savings by using [F-18]FDOPA PET to fast-track treatment-resistant patients to clozapine. Overall, the findings suggest that [F-18]FDOPA PET dopamine imaging has the potential to serve as a biomarker to guide treatment choice for patients with schizophrenia.

NEUROPSYCHOPHARMACOLOGY (2021)

Article Psychiatry

Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level A Mega-analysis of Individual Participant-Level Data

Kate Merritt et al.

Summary: The study suggests that lower brain glutamate levels in patients with schizophrenia may be associated with exposure to antipsychotic medication rather than age-related decline. Higher brain glutamate levels may act as a biomarker of illness severity in schizophrenia.

JAMA PSYCHIATRY (2021)

Article Psychiatry

Glutamate connectivity associations converge upon the salience network in schizophrenia and healthy controls

Robert A. McCutcheon et al.

Summary: The study found that frontal cortex glutamate concentrations are associated with inter-areal functional connectivity of a network that localizes to the salience network. Changes in network connectivity in response to glutamate modulation show an opposite effect compared to the relationship observed at baseline, which may complicate pharmacological attempts to simultaneously correct glutamatergic and connectivity aberrations.

TRANSLATIONAL PSYCHIATRY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Test-Retest Reliability of the Brain Metabolites GABA and Glx With JPRESS, PRESS, and MEGA-PRESS MRS Sequences in vivo at 3T

Arwa Baeshen et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)

Review Psychiatry

Schizophrenia-An Overview

Robert A. McCutcheon et al.

JAMA PSYCHIATRY (2020)

Article Psychiatry

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment

Robert A. McCutcheon et al.

WORLD PSYCHIATRY (2020)

Review Neurosciences

Endocannabinoid modulation of dopamine neurotransmission

Dan P. Covey et al.

NEUROPHARMACOLOGY (2017)

Review Radiology, Nuclear Medicine & Medical Imaging

The Trouble With Quality Filtering Based on Relative Cramer-Rao Lower Bounds

Roland Kreis

MAGNETIC RESONANCE IN MEDICINE (2016)

Article Biochemical Research Methods

Analyzing the Effects of Psychotropic Drugs on Metabolite Profiles in Rat Brain Using 1H NMR Spectroscopy

Gerard A. McLoughlin et al.

JOURNAL OF PROTEOME RESEARCH (2009)

Review Behavioral Sciences

The dopaminergic basis of human behaviors: A review of molecular imaging studies

Alice Egerton et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)

Review Psychiatry

The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway

Oliver D. Howes et al.

SCHIZOPHRENIA BULLETIN (2009)